Research Roundup

Debbie Rigby 25/11/2025

Debbie Rigby takes a look at the latest in research news Cardiovascular Effects and Tolerability of GLP-1 Receptor Agonists A large systematic review and meta-analysis has shown that GLP-1 RAs reduce mortality and MACE in high-risk populations, highlighting benefits beyond glycaemic control. GLP-1 RAs reduced serious adverse events (−9%), myocardial infarction (−15%), acute kidney failure

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

This web site is intended for Australian pharmacy professionals and is not a substitute for independent professional advice. Information and interactions contained in this website are for information purposes only and are not intended to be used to diagnose, treat, cure or prevent any disease. Further the accuracy, currency and completeness of the information available on this web site cannot be guaranteed. APPco Pty Ltd, its affiliates and their respective servants and agents do not accept any liability for any injury, loss or damage incurred by use of or reliance on the information made available via or through ajp.com.au whether arising from negligence or otherwise.

Research Roundup

Previous Vaccines ‘safe, effective and not associated with autism’: TGA

Next Are online challengers making their move?

MENU

ajp.com.au

Previous Vaccines ‘safe, effective and not associated with autism’: TGA

Next Are online challengers making their move?

MENU

ajp.com.au

Tags

Hi there! 👋 Looks like you’re not logged in.